The hypothesis seems to be supported by two genetic findings: (1) genetic forms of AD produce an increase in βA or βA fibrillogenic properties and are sufficient to induce typical AD pathology [32]; (2) APOE e4 appears to increase AD risk by affecting βA seeding and clearance [33,34]. The gene discussed is APOE; the disease is Alzheimer disease.